Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: A phase 2b, randomised, double-blind, placebo-controlled trial

Reich, Daniel S, Arnold, Douglas L, Vermersch, Patrick · The Lancet Neurology · 2021